Obesity-related, metabolic asthma: a new role for glucagon-like peptide 1 agonists.
作者信息
Nguyen Dan-Vinh, Linderholm Angela, Haczku Angela, Kenyon Nicholas
机构信息
Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of California Davis, Sacramento, CA 95817, USA.
Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of California Davis, Sacramento, CA 95817, USA.
出版信息
Lancet Respir Med. 2017 Mar;5(3):162-164. doi: 10.1016/S2213-2600(17)30051-6.
Abstract
摘要
相似文献
1
Obesity-related, metabolic asthma: a new role for glucagon-like peptide 1 agonists.肥胖相关的代谢性哮喘：胰高血糖素样肽-1激动剂的新作用
Lancet Respir Med. 2017 Mar;5(3):162-164. doi: 10.1016/S2213-2600(17)30051-6.
2
[GLP-1 derivatives, for the prevention and treatment of type 2 diabetes mellitus].[用于预防和治疗2型糖尿病的胰高血糖素样肽-1衍生物]
Nihon Shokakibyo Gakkai Zasshi. 2005 Nov;102(11):1398-404.
3
The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective.胰高血糖素样肽-1 在生殖中的作用：从生理学到治疗学的角度。
Hum Reprod Update. 2019 Jul 1;25(4):504-517. doi: 10.1093/humupd/dmz019.
4
Bariatric surgery provides unparalleled metabolic benefits.减肥手术能带来无可比拟的代谢益处。
Obes Surg. 2007 Feb;17(2):193-4. doi: 10.1007/s11695-007-9046-x.
5
Obesity and obesity related co-morbidities in a referral population of children with asthma.哮喘转诊儿童人群中的肥胖及与肥胖相关的合并症
Pediatr Pulmonol. 2009 Sep;44(9):877-84. doi: 10.1002/ppul.21065.
6
Severe asthma is associated with metabolic syndrome in Brazilian adolescents.重度哮喘与巴西青少年的代谢综合征有关。
J Allergy Clin Immunol. 2018 May;141(5):1947-1949.e4. doi: 10.1016/j.jaci.2018.01.026. Epub 2018 Feb 7.
7
Mitochondrial Dysfunction Linking Obesity and Asthma.线粒体功能障碍与肥胖和哮喘的关系。
Ann Am Thorac Soc. 2017 Nov;14(Supplement_5):S368-S373. doi: 10.1513/AnnalsATS.201701-042AW.
8
The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity.联合补充肌醇对合并代谢综合征和肥胖的妊娠孕妇代谢状况的影响。
Am J Obstet Gynecol. 2016 Oct;215(4):503.e1-8. doi: 10.1016/j.ajog.2016.05.038. Epub 2016 May 30.
9
Newer GLP-1 receptor agonists and obesity-diabetes.新型 GLP-1 受体激动剂与肥胖-糖尿病。
Peptides. 2018 Feb;100:61-67. doi: 10.1016/j.peptides.2017.12.009.
10
Liraglutide therapy in obese people with type 2 diabetes - experience of a weight management centre.利拉鲁肽治疗肥胖的2型糖尿病患者——一家体重管理中心的经验
Eur J Intern Med. 2014 Mar;25(3):e38-9. doi: 10.1016/j.ejim.2013.12.009. Epub 2014 Jan 10.
引用本文的文献
1
Obesity-related Asthma: A Pathobiology-based Overview of Existing and Emerging Treatment Approaches.肥胖相关性哮喘：基于病理生理学的现有和新兴治疗方法概述。
Am J Respir Crit Care Med. 2024 Nov 15;210(10):1186-1200. doi: 10.1164/rccm.202406-1166SO.
2
Beneficial Influence of Exendin-4 on Specific Organs and Mechanisms Favourable for the Elderly with Concomitant Obstructive Lung Diseases.艾塞那肽-4对伴有阻塞性肺病的老年人特定器官及有利机制的有益影响。
Brain Sci. 2022 Aug 17;12(8):1090. doi: 10.3390/brainsci12081090.
3
Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes.在有和没有 2 型糖尿病的个体中，递增口服葡萄糖剂量和相应等血糖静脉葡萄糖输注期间可溶性 AGE 受体 (sRAGE) 的循环水平。
Nutrients. 2020 Sep 24;12(10):2928. doi: 10.3390/nu12102928.
本文引用的文献
1
Glucagon-like peptide-1 receptor expression on human eosinophils and its regulation of eosinophil activation.胰高血糖素样肽-1受体在人嗜酸性粒细胞上的表达及其对嗜酸性粒细胞活化的调节。
Clin Exp Allergy. 2017 Mar;47(3):331-338. doi: 10.1111/cea.12860. Epub 2017 Jan 28.
2
Glucagon-Like Peptide 1 Receptor: A Novel Pharmacological Target for Treating Human Bronchial Hyperresponsiveness.胰高血糖素样肽-1受体：治疗人类支气管高反应性的新型药理学靶点。
Am J Respir Cell Mol Biol. 2016 Dec;55(6):804-814. doi: 10.1165/rcmb.2015-0311OC.
3
The receptor for advanced glycation end products is required for β-catenin stabilization in a chemical-induced asthma model.在化学诱导的哮喘模型中，晚期糖基化终末产物受体对于β-连环蛋白的稳定是必需的。
Br J Pharmacol. 2016 Sep;173(17):2600-13. doi: 10.1111/bph.13539. Epub 2016 Jul 27.
4
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.利拉鲁肽与2型糖尿病患者的心血管结局
N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.
5
Metabolic Syndrome and the Lung.代谢综合征与肺脏
Chest. 2016 Jun;149(6):1525-34. doi: 10.1016/j.chest.2015.12.034. Epub 2016 Jan 20.
6
Effect of diet-derived advanced glycation end products on inflammation.饮食源性晚期糖基化终产物对炎症的影响。
Nutr Rev. 2015 Nov;73(11):737-59. doi: 10.1093/nutrit/nuv030. Epub 2015 Sep 15.
7
Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice.胰高血糖素样肽-1（GLP-1）通过蛋白激酶A（PKA）依赖性核因子-κB（NF-κB）信号通路调节卵清蛋白诱导的小鼠气道炎症和黏液分泌。
Int J Mol Sci. 2015 Aug 26;16(9):20195-211. doi: 10.3390/ijms160920195.
8
Metabolic Syndrome Is Associated with Increased Oxo-Nitrative Stress and Asthma-Like Changes in Lungs.代谢综合征与氧化亚硝化应激增加及肺部类似哮喘的变化有关。
PLoS One. 2015 Jun 22;10(6):e0129850. doi: 10.1371/journal.pone.0129850. eCollection 2015.
9
GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond.胰高血糖素样肽-1受体激动剂：减肥及其他方面的非血糖临床效果
Obesity (Silver Spring). 2015 Jun;23(6):1119-29. doi: 10.1002/oby.21107. Epub 2015 May 9.
10
Arginine and nitric oxide pathways in obesity-associated asthma.肥胖相关性哮喘中的精氨酸和一氧化氮途径
J Allergy (Cairo). 2013;2013:714595. doi: 10.1155/2013/714595. Epub 2013 Apr 21.
Zotero 插件